thioridazine has been researched along with Atherogenesis in 1 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, MC | 1 |
| Ding, HY | 1 |
| Huang, YH | 1 |
| Cheng, CK | 1 |
| Lau, CW | 1 |
| Xia, Y | 1 |
| Yao, XQ | 1 |
| Wang, L | 1 |
| Huang, Y | 1 |
1 other study available for thioridazine and Atherogenesis
| Article | Year |
|---|---|
Thioridazine protects against disturbed flow-induced atherosclerosis by inhibiting RhoA/YAP-mediated endothelial inflammation.
Topics: Animals; Atherosclerosis; Endothelial Cells; Humans; Inflammation; Mice; rhoA GTP-Binding Protein; T | 2023 |